Understanding their similarities and differences helps beginners read ingredient labels with greater confidence
Using PCCA Suppository Bases PCCA MBK (Fatty Acid) (PCCA #30-1056) Melting fatty base Is a combination of hydrogenated vegetable oil and PEG-8-distearate (a surfactant) MucoLox (PCCA #30-4782) may be added at 10% to help with mucoadhesion Base A (Polyethylene Glycol 1450 MW, NF) (PCCA #30-1013) Dissolving PEG base Base F (Witepsol H15 ) NF (PCCA #30-4840) Melting fatty base Composed of hydrogenated coco-glycerides When using Base F in a suppository, 5% Base G (Almond Oil NF (Sweet)) (PCCA #30-1027) is added to prevent cracking PCCA Polypeg (PCCA #30-2883) Dissolving PEG base A blended polyethylene glycol suppository base with polysorbate 80
FDA laboratory testing found excessive bacterial endotoxin in samples, with some results reaching approximately five times the calculated appropriate limit
The 2024 NICE guideline asks clinicians to tailor timing to your symptoms and review it, rather than treating one figure as fixed
[12] showed that CYP activity can be modulated by both dose and treatment duration
Abstract Systemic vasculitis, common forms of which include anti-neutrophil cytoplasmic antibody-associated small-vessel vasculitis, large-vessel vasculitis and Behet syndrome, are frequently complicated by arterial or venous thrombotic events (AVTEs)